Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
Janssen YJ, Helmerhorst F, Frölich M, Roelfsema F. Janssen YJ, et al. Among authors: roelfsema f. J Clin Endocrinol Metab. 2000 Jan;85(1):464-7. doi: 10.1210/jcem.85.1.6311. J Clin Endocrinol Metab. 2000. PMID: 10634425 Clinical Trial.
The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
Roelfsema F, Goslings BM, Frölich M, Moolenaar AJ, Seters AP, Van Slooten H. Roelfsema F, et al. Clin Endocrinol (Oxf). 1979;11(2):235-44. doi: 10.1111/j.1365-2265.1979.tb03069.x. Clin Endocrinol (Oxf). 1979. PMID: 114344
Effect of administration of growth hormone on plasma and intracellular levels of thyroxine and tri-iodothyronine in thyroidectomized thyroxine-treated rats.
Geelhoed-Duijvestijn PH, Roelfsema F, Schröder-van der Elst JP, van Doorn J, van der Heide D. Geelhoed-Duijvestijn PH, et al. Among authors: roelfsema f. J Endocrinol. 1992 Apr;133(1):45-9. doi: 10.1677/joe.0.1330045. J Endocrinol. 1992. PMID: 1517706
Octreotide treatment in acromegaly: a comparison between pen-treated and pump-treated patients in a cross-over study.
Roelfsema F, Frölich M, de Boer H, Harris AG. Roelfsema F, et al. Acta Endocrinol (Copenh). 1991 Jul;125(1):43-8. doi: 10.1530/acta.0.1250043. Acta Endocrinol (Copenh). 1991. PMID: 1872124
The interaction of GHRH with TRH in acromegaly: a controlled study.
Looij BJ, Roelfsema F, Frölich M, Nieuwenhuijzen Kruseman AC. Looij BJ, et al. Among authors: roelfsema f. Acta Endocrinol (Copenh). 1991 Oct;125(4):337-41. doi: 10.1530/acta.0.1250337. Acta Endocrinol (Copenh). 1991. PMID: 1957553 Clinical Trial.
Pulsatile thyrotropin release and thyroid function in acromegalics before and during subcutaneous octreotide infusion.
Roelfsema F, Frölich M. Roelfsema F, et al. J Clin Endocrinol Metab. 1991 Jan;72(1):77-82. doi: 10.1210/jcem-72-1-77. J Clin Endocrinol Metab. 1991. PMID: 1986030
The influence of octreotide treatment on pulsatile growth hormone release in acromegaly.
Roelfsema F, de Boer H, Frölich M. Roelfsema F, et al. Clin Endocrinol (Oxf). 1990 Aug;33(2):297-306. doi: 10.1111/j.1365-2265.1990.tb00494.x. Clin Endocrinol (Oxf). 1990. PMID: 2225485
Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery.
Geelhoed-Duijvestijn PH, Bussemaker JK, Roelfsema F. Geelhoed-Duijvestijn PH, et al. Among authors: roelfsema f. Acta Endocrinol (Copenh). 1989 Aug;121(2):207-15. doi: 10.1530/acta.0.1210207. Acta Endocrinol (Copenh). 1989. PMID: 2505466
Plasma growth hormone profiles and sleep: a study of 13 treated acromegalics.
de Boer H, Roelfsema F, Frölich M, Kamphuisen HA, van Seters AP. de Boer H, et al. Among authors: roelfsema f. Clin Endocrinol (Oxf). 1989 Mar;30(3):251-61. doi: 10.1111/j.1365-2265.1989.tb02233.x. Clin Endocrinol (Oxf). 1989. PMID: 2512036
Prolactin and luteinizing hormone profiles of cured acromegalic subjects.
Roelfsema F, Frölich M, de Boer H. Roelfsema F, et al. Clin Endocrinol (Oxf). 1989 Oct;31(4):439-51. doi: 10.1111/j.1365-2265.1989.tb01268.x. Clin Endocrinol (Oxf). 1989. PMID: 2516783
250 results
Jump to page